The effect of hormonal status on the expression of estrogen and progesterone receptor in vaginal wall and periurethral tissue in urogynecological patients
- PMID: 20673608
- DOI: 10.1016/j.ejogrb.2010.07.006
The effect of hormonal status on the expression of estrogen and progesterone receptor in vaginal wall and periurethral tissue in urogynecological patients
Abstract
Objective: Our objective was to study the expression of estrogen receptor (ER) isoforms ER alpha (α) and ER beta (β) and of progesterone receptor (PR) in the vaginal wall and in periurethral tissue of women who underwent urogynecological surgical treatment with reference to estrogen status.
Study design: The study included 89 patients undergoing vaginal surgery for urogynecological conditions. Patients' history and clinical data including estrogen status and body mass index (BMI) were evaluated. Biopsies from the vaginal wall and from periurethral tissue were obtained during surgery. The expression of ER α and β and of PR in vaginal wall and periurethral tissue was measured by RT-PCR.
Results: Nine patients were premenopausal. Eighty women were menopausal, of whom 21 were taking estrogen/progestin replacement therapy (HRT), 20 used local estrogen, and 39 had no endocrine treatment. Neither BMI nor age had any influence on the expression of ER and PR. Menopausal women showed a higher amount of PR expression in vaginal tissue than premenopausal women. Women with no endocrine treatment showed a lower amount of ER β expression in vaginal tissue.
Conclusion: Steroid receptors are expressed in periurethral and vaginal tissue. The receptor expression varies with hormonal changes only in vaginal tissue. Vaginal tissue seems to be more sensitive to estrogen than periurethral tissue.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women.Am J Obstet Gynecol. 2001 Dec;185(6):1325-30; discussion 1330-1. doi: 10.1067/mob.2001.119627. Am J Obstet Gynecol. 2001. PMID: 11744904
-
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.Breast Cancer Res Treat. 2009 Jul;116(1):131-43. doi: 10.1007/s10549-008-0144-9. Epub 2008 Jul 31. Breast Cancer Res Treat. 2009. PMID: 18668363 Clinical Trial.
-
Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.Cancer Res. 2001 Mar 1;61(5):1919-26. Cancer Res. 2001. PMID: 11280747
-
Receptor isoforms that mediate estrogen and progestagen action in the female lower urinary tract.J Urol. 2009 Mar;181(3):1474-82. doi: 10.1016/j.juro.2008.10.104. Epub 2009 Jan 20. J Urol. 2009. PMID: 19157432
-
Change of steroid receptor expression in the posterior vaginal wall after local estrogen therapy.Eur J Obstet Gynecol Reprod Biol. 2015 Apr;187:45-50. doi: 10.1016/j.ejogrb.2015.02.021. Epub 2015 Feb 21. Eur J Obstet Gynecol Reprod Biol. 2015. PMID: 25748487 Review.
Cited by
-
Improvements of vaginal atrophy without systemic side effects after topical application of Pueraria mirifica, a phytoestrogen-rich herb, in postmenopausal cynomolgus macaques.J Reprod Dev. 2014;60(3):238-45. doi: 10.1262/jrd.2013-144. Epub 2014 Apr 21. J Reprod Dev. 2014. PMID: 24748397 Free PMC article. Clinical Trial.
-
The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women.Front Cell Infect Microbiol. 2019 May 1;9:133. doi: 10.3389/fcimb.2019.00133. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31119104 Free PMC article. Review.
-
The effect of genital and lower urinary tract symptoms on steroid receptor expression in women with genital prolapse.Int Urogynecol J. 2011 Jun;22(6):705-12. doi: 10.1007/s00192-010-1327-6. Epub 2010 Nov 24. Int Urogynecol J. 2011. PMID: 21107812
-
Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy.Int Urogynecol J. 2019 Feb;30(2):251-256. doi: 10.1007/s00192-018-3682-7. Epub 2018 Jun 26. Int Urogynecol J. 2019. PMID: 29946829
-
Multidisciplinary overview of vaginal atrophy and associated genitourinary symptoms in postmenopausal women.Sex Med. 2013 Dec;1(2):44-53. doi: 10.1002/sm2.17. Sex Med. 2013. PMID: 25356287 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials